Literature DB >> 11487539

Ki-ras proto-oncogene mutations in sporadic colorectal adenomas: relationship to histologic and clinical characteristics.

T Maltzman1, K Knoll, M E Martinez, T Byers, B R Stevens, J R Marshall, M E Reid, J Einspahr, N Hart, A K Bhattacharyya, C B Kramer, R Sampliner, D S Alberts, D J Ahnen.   

Abstract

BACKGROUND & AIMS: [corrected] The goal of this study was to examine the relationship between Ki-ras mutations in colorectal adenomas and characteristics of both the subject (age, gender, and family/personal history of colonic neoplasia) and the adenoma (multiplicity, size, location, and histologic features).
METHODS: Ki-ras mutations were detected by direct sequencing in 738 adenomatous polyps removed at baseline from 639 participants in a nutritional trial of adenoma recurrence.
RESULTS: Ki-ras mutations were detected in 17.2% of the adenomas. Ki-ras mutations were unrelated to gender, family, or personal history of colonic neoplasia, location within the colorectum, or adenoma multiplicity, but were more common in older subjects (P = 0.01 for trend), in larger adenomas (P < 0.0001 for trend), in adenomas with villous histology (odds ratio [OR], 3.2; 95% confidence interval [CI], 2.1-4.9 vs. tubular), and in adenomas with high-grade dysplasia (32.0% vs. 13.6%; OR, 3.0; 95% CI, 1.9-4.6 vs. low-grade dysplasia). Multivariate analysis showed Ki-ras mutations to be independently associated with subject age (P = 0.01 for trend), tubulovillous/villous histology (OR, 2.3; 95% CI, 1.5-3.7), and high-grade dysplasia (OR, 1.9; 95% CI, 1.2-3.1). Adenoma size was not independently related to Ki-ras mutation.
CONCLUSIONS: Ki-ras mutations are associated with the histologic features of adenoma progression (villous histology and high-grade dysplasia) rather than with adenoma growth.

Entities:  

Mesh:

Year:  2001        PMID: 11487539     DOI: 10.1053/gast.2001.26278

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  19 in total

1.  Molecular validation of the modified Vienna classification of colorectal tumors.

Authors:  Tamotsu Sugai; Wataru Habano; Noriyuki Uesugi; Yu-Fei Jiao; Shin-ichi Nakamura; Kimihiko Sato; Toshimi Chiba; Motohiro Ishii
Journal:  J Mol Diagn       Date:  2002-11       Impact factor: 5.568

2.  Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics.

Authors:  Janine G Einspahr; Maria Elena Martinez; Ruiyun Jiang; Chiu-Hsieh Hsu; Asif Rashid; Achyut K Bhattacharrya; Dennis J Ahnen; Elizabeth T Jacobs; P Scott Houlihan; C Renee Webb; David S Alberts; Stanley R Hamilton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-08       Impact factor: 4.254

Review 3.  Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions.

Authors:  Paul Lochhead; Andrew T Chan; Edward Giovannucci; Charles S Fuchs; Kana Wu; Reiko Nishihara; Michael O'Brien; Shuji Ogino
Journal:  Am J Gastroenterol       Date:  2014-06-17       Impact factor: 10.864

4.  Distinct chromosomal imbalances in nonpolypoid and polypoid colorectal adenomas indicate different genetic pathways in the development of colorectal neoplasms.

Authors:  Hedwig Richter; Premysl Slezak; Axel Walch; Martin Werner; Herbert Braselmann; Edgar Jaramillo; Ake Ost; Ichiro Hirata; Kazuya Takahama; Horst Zitzelsberger
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

5.  Detection of mutated K-ras DNA in urine, plasma, and serum of patients with colorectal carcinoma or adenomatous polyps.

Authors:  Ying-Hsiu Su; Mengjun Wang; Dean E Brenner; Pamela A Norton; Timothy M Block
Journal:  Ann N Y Acad Sci       Date:  2008-08       Impact factor: 5.691

6.  Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma.

Authors:  Karoliina Stefanius; Laura Ylitalo; Anne Tuomisto; Rami Kuivila; Tiina Kantola; Päivi Sirniö; Tuomo J Karttunen; Markus J Mäkinen
Journal:  Histopathology       Date:  2011-04-04       Impact factor: 5.087

Review 7.  Smad phosphoisoform signaling specificity: the right place at the right time.

Authors:  Koichi Matsuzaki
Journal:  Carcinogenesis       Date:  2011-07-27       Impact factor: 4.944

8.  Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer.

Authors:  J R Jass; K Baker; I Zlobec; T Higuchi; M Barker; D Buchanan; J Young
Journal:  Histopathology       Date:  2006-08       Impact factor: 5.087

9.  Prognostic Impact of del(17p) and del(22q) as assessed by interphase FISH in sporadic colorectal carcinomas.

Authors:  María González-González; Luís Muñoz-Bellvis; Carlos Mackintosh; Celia Fontanillo; M Laura Gutiérrez; M Mar Abad; Oscar Bengoechea; Cristina Teodosio; Emilio Fonseca; Manuel Fuentes; Javier De Las Rivas; Alberto Orfao; José María Sayagués
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

10.  Genetic and epigenetic alterations of Ras signalling pathway in colorectal neoplasia: analysis based on tumour clinicopathological features.

Authors:  K Harada; S Hiraoka; J Kato; J Horii; H Fujita; K Sakaguchi; Y Shiratori
Journal:  Br J Cancer       Date:  2007-10-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.